Atlantic Coastal Acquisition Corp. II - Class A Common Stock (ACAB)
5.7700
+0.00 (0.00%)
NASDAQ · Last Trade: Apr 28th, 9:01 AM EDT
Detailed Quote
Previous Close
5.770
Open
-
Bid
6.400
Ask
7.850
Day's Range
N/A - N/A
52 Week Range
5.770 - 13.00
Volume
0
Market Cap
-
PE Ratio (TTM)
-
EPS (TTM)
-
Dividend & Yield
N/A (N/A)
1 Month Average Volume
-
Chart
About Atlantic Coastal Acquisition Corp. II - Class A Common Stock (ACAB)
Atlantic Coastal Acquisition Corp. II is a special purpose acquisition company (SPAC) that focuses on identifying and merging with an existing company, particularly in the technology, media, telecommunications, and consumer sectors. By raising capital through public offerings, the company aims to provide a platform for growth and innovation by facilitating access to resources, guidance, and strategic direction for its targeted acquisition. Through this approach, Atlantic Coastal seeks to create value for its shareholders while helping the chosen company expand and thrive in its respective market. Read More
WOBURN, Mass. and NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Abpro Corporation (“Abpro”), a biotech company with the mission of improving the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies, and Atlantic Coastal Acquisition Corp. II (NASDAQ: ACAB), a special purpose acquisition company (“Atlantic Coastal”), today announced the filing of a registration statement on Form S-4 (the “Registration Statement”) with the U.S. Securities and Exchange Commission (“SEC”) on January 19, 2024, which includes a preliminary proxy statement and prospectus in connection with its proposed business combination.
